Advertisement

Product › Details
IFNalpha-Kinoid (IFNa-Kinoïd)
![]() |
Next higher product group | therapeutic vaccine |
![]() |
Status | 2015-03-23 development existent |
![]() |
Organisation | Neovacs S.A. (Euronext Growth Paris: ALNEV) |
Group | Neovacs (Group) | |
Record changed: 2023-07-10 |
Advertisement

More documents for IFNalpha-Kinoid (IFNa-Kinoïd)
- [1] Neovacs S.A.. (9/11/18). "Press Release: Neovacs Announces that Its Partner Biosense Global Has Exercised Its Option to Acquire the Exclusive Licence for IFNalpha Kinoid to Treat Lupus in China". Paris & Boston, MA....
- [2] Neovacs S.A.. (2/22/18). "Press Release: Neovacs Strengthens Its Intellectual Property in the USA". Paris & Boston, MA....
- [3] Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris....
- [4] Neovacs S.A.. (2/21/17). "Press Release: Neovacs and BioSense Sign Option Agreement Worth up to €65 Million plus Royalties for Chinese Development and Commercial Rights to IFNalpha Kinoid for Lupus and Dermatomyositis". Paris....
- [5] ActeaVentures GmbH. (2/21/17). "Press Release: ActeaVentures Successfully Assisted Neovacs in Partnering IFN-K for Lupus to BioSense Global for the Chinese Market". Karlsruhe....
- [6] Neovacs S.A.. (2/9/17). "Press Release: Neovacs Issued New Broad Patent in China for IFNalpha Kinoid". Paris....
- [7] Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris....
- [8] Neovacs S.A.. (1/25/17). "Press Release: Neovacs Reports First Positive Immunogenicity Results for IFN alpha Kinoid in Model of Type 1 Diabetes". Paris & Boston, MA....
- [9] Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top